Midsagittal corpus callosum area and conversion to multiple sclerosis after clinically isolated syndrome: A multicentre Australian cohort study

Patients presenting with clinically isolated syndrome ( CIS ) may proceed to clinically definite multiple sclerosis ( CDMS ). Midsagittal corpus callosum area ( CCA ) is a surrogate marker for callosal atrophy, and can be obtained from a standard MRI study. This study explores the relationship between CCA measured at CIS presentation (baseline) and at 5 years post presentation, with conversion from CIS to CDMS . The association between CCA and markers of disability progression is explored. Methods Corpus callosum area was measured on MRI scans at presentation and 5‐year review following diagnosis of a first demyelinating event, or evidence of progressive MS , in 143 participants in the Ausimmune/AusLong Study. Relationships between CCA (at baseline and follow‐up) and clinical outcomes were assessed. Results Mean CCA at baseline study was 6.63 cm 2 ( SD 1.01). Patients who converted to MS by 5‐year review ( n  = 100) had a significantly smaller mean CCA at follow‐up (6.22 vs. 6.74, P  = 0.007). Greater CCA reduction was associated with higher annualized relapse rate over follow‐up. Conclusion Baseline CCA obtained from standard MRI protocols may be compared with subsequent MRI examinations as a surrogate for neurodegeneration and cerebral atrophy in patients with MS . This study demonstrates an association between CCA and disability in individuals presenting with CIS who convert to MS .